Maze Therapeutics (MAZE) insider trading in the last 6 months

4 insiders sold $1.1M. No buys.

Quality Score8Average

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 16 tradesSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Form 4 filings, newest first

SellJason V. Coloma$293KChief Executive Officerat $26.01 on Sep 3, filed Sep 4

SellJason V. ColomaChief Executive Officer$293Kat $26.01 on Sep 3, filed Sep 4

SellJason V. Coloma$260KChief Executive Officerat $26.38 on Sep 2, filed Sep 4

SellJason V. ColomaChief Executive Officer$260Kat $26.38 on Sep 2, filed Sep 4

SellHarold Bernstein$133KPresident, R&D & CMOat $26.01 on Sep 3, filed Sep 4

SellHarold BernsteinPresident, R&D & CMO$133Kat $26.01 on Sep 3, filed Sep 4

From SEC Form 4s, the newest filed Sep 4, 2026 · Insiders have 2 business days to file a trade

13 more filings on MAZE in the last 6 months, for Pro members. See them free →

Pro members see every filing on MAZE with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at Maze Therapeutics

Insider trades by person

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Questions about MAZE's insider trades

As of Nov 10, 2026: Maze Therapeutics (MAZE) has 16 insider filings on record in the last 6 months, the newest filed Sep 4, 2026. Its Quality Score is 8 (Average). Scores as of 11:35 PM ET, 15 minutes behind.

Are MAZE insiders buying or selling?

4 insiders sold $1.1M across 16 filings in the last 6 months. No open-⁠market buys on record. The newest filing: Jason V. Coloma, Chief Executive Officer, sold $293K on Sep 3, 2026.

Who are MAZE's biggest insider sellers?

By the dollars of their sales in the last 6 months: Jason V. Coloma (Chief Executive Officer), 4 sales; Harold Bernstein (President, R&D & CMO), 4 sales; Atul Dandekar (CSBO), 4 sales. 4 insiders sold in all.

When did an MAZE insider last buy?

No MAZE insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by Jason V. Coloma on Sep 3, 2026.

Maze Therapeutics's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech.

Maze Therapeutics (MAZE) insider trading in the last 6 months

Form 4 filings, newest first

Who files at Maze Therapeutics

Questions about MAZE's insider trades

Every insider trade, with its stock's score.